Actionable news
All posts from Actionable news
Actionable news in PTCT: PTC Therapeutics, Inc.,

PTC Therapeutics' (PTCT) CEO Stuart Peltz on Q3 2015 Results - Earnings Call Transcript


Good day, ladies and gentlemen and welcome to the PTC Therapeutics Third Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session. [Operator Instructions] As a remainder, this conference call may be recorded.

I'd now like to turn the conference over to Emily Hill of Investor Relations. You may begin.

Emily Hill - IR

Thank you. Welcome to our conference call. Today we will discuss PTC's third quarter 2015 and year to date financial results, our ongoing commercial launch activities for Translarna and Duchenne muscular dystrophy results from our Phase 3 ACT DMD clinical trial and other corporate update.

Before we start, let me remind you that today's call will include forward-looking statements based on current expectations. These include statements about our future expectations, regarding clinical developments, regulatory, and commercialization...